Table 1.
Pre-infection data and post-COVID symptoms of the total sample.
| Total Sample (n = 408) | |
|---|---|
| Age, mean (SD), years | 58.5 (14.0) |
| Sex, female n (%) | 198 (48.5%) |
| Weight, mean (SD), kg. | 80.1 (17.0) |
| Height, mean (SD), cm. | 166.5 (9.5) |
| Number of co-morbidities, mean (SD) | 1.2 (1.0) |
| Medical co-morbidities, n (%) | |
| Hypertension | 143 (35.0%) |
| Obesity | 98 (24.0%) |
| Diabetes | 43 (10.5%) |
| Asthma | 38 (9.3%) |
| Cardiovascular Diseases | 38 (9.3%) |
| Chronic Obstructive Pulmonary Disease | 10 (2.5%) |
| Rheumatological Diseases | 3 (0.7%) |
| Number of post-COVID symptoms, mean (SD) | 3.0 (1.7) |
| Post-COVID symptoms, n (%) | |
| Fatigue | 283 (69.3%) |
| Pain Symptoms | 167 (40.9%) |
| Memory Loss | 111 (27.2%) |
| Hair Loss | 105 (25.7%) |
| Concentration Loss | 47 (11.5%) |
| Cognitive Blunting—Brain Fog | 45 (11.0%) |
| Dyspnoea | 80 (19.6%) |
| Ocular Disorders | 45 (11.0%) |
| Skin Rashes | 56 (13.7%) |
| Anosmia | 39 (9.5%) |
| Gastrointestinal Disorders | 29 (7.1%) |
| Ageusia | 23 (5.6%) |
| Days in hospital, mean (SD) | 8.2 (7.8) |